The Patent Finder

Tibeay Biosciences B.V.

8 patents currently held · Updated Nov 19, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Verinos Operations GmbH (to 2026)

0
Ending by 2030
Mar 2035
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 8, 2027
    The maintenance fee for Solid Pharmaceutical Compositions Comprising Biopterin Derivatives and Uses of Such Compositions (US 11,717,522) comes due Feb 8, 2027. Unpaid by Aug 9, 2027, it lapses early.
  • 1 fee due Jun 3, 2027
    The maintenance fee for Solid Pharmaceutical Compositions Comprising Biopterin Derivatives and Uses of Such Compositions (US 10,493,075) comes due Jun 3, 2027. Unpaid by Dec 3, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,016,431Solid Pharmaceutical Compositions Comprising Biopterin Derivatives and Uses of Such Compositions
In force
 · High confidence
In forceHigh confidence
US 10,493,075Solid Pharmaceutical Compositions Comprising Biopterin Derivatives and Uses of Such Compositions
In force
 · High confidence
In forceHigh confidence
US 10,925,877Solid Pharmaceutical Compositions Comprising Biopterin Derivatives and Uses of Such Compositions
In force
 · High confidence
In forceHigh confidence
US 12,458,644Process for Preparing Solutions Comprising Biopterin Derivatives
In force
 · High confidence
In forceHigh confidence
US 9,895,372Solid Pharmaceutical Compositions Comprising Biopterin Derivatives and Uses of Such Compositions
In force
 · High confidence
In forceHigh confidence
US 11,717,522Solid Pharmaceutical Compositions Comprising Biopterin Derivatives and Uses of Such Compositions
In force
 · High confidence
In forceHigh confidence
US 12,171,766Methods of Treating Patients Suffering from Brain Injury and Methods of Increasing the Value of the Extended Glasgow Outcome Scale of Patients Suffering from Brain Injury
In force
 · High confidence
In forceHigh confidence
US 12,465,609Methods of Treating Patients Suffering from a Disease Condition or Disorder That Is Associated with an Increased Glutamate Level
In force
 · High confidence
In forceHigh confidence

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited